In my own clinical practice, Ive seen some patients have transformative journeys on GLP-1s while others dont seem to lose weight at all or even gain more
Compared with the metformin plus sulfonylurea combination, the lowest risk for all three investigated endpoints, namely MACE, severe hypoglycemia, and all cause-mortality, was seen for people treated with metformin in combination with SGLT2is and GLP-1RAs (HR, 0.53 [95% CI, 0.350.80] for MACE
Focus on Gut Health : Including probiotic foods and fiber supports a healthy microbiome, which aids GLP-1 release
The most common contributor is likely reduced caloric intake
Following treatment initiation, a downregulation in TNF-, IL-6, and IL-8 was noted, along with reduced tissue-degrading enzyme expression[20]
Advances in analytical instrumentation and data analysis software are expanding the capabilities of peptide characterization